Vedolizumab's Real-World impact on Crohn's disease explored
NCT ID NCT05192863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed observational study followed 72 adults with moderate to severe Crohn's disease who were starting vedolizumab treatment. The goal was to see if the drug could lead to complete remission—meaning no symptoms, normal inflammation markers, and healed bowel walls—after 12 months. Researchers used ultrasound to check bowel inflammation, alongside standard symptom scores and lab tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.U. Federico II
Naples, 80131, Italy
-
ASST Fatebenefratelli Sacco
Milan, 20157, Italy
-
Fondazione Ca' Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
Ospedale ASST Rhodense
Rho, Milano, 20017, Italy
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Rabin Medical Center
Petah Tikva, 4941492, Israel
-
Sheba Medical Center
Ramat Gan, 5262000, Israel
-
University of Calgary
Calgary, Alberta, T2N 4N1, Canada
-
University of Saskatchewan
Saskatoon, Saskatchewan, S7N 0W8, Canada